erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.

lawmakers should revisit that idea when lepage is no longer in office next year.. we have let patients down, admits senior northern ireland civil servant